PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study

Podobne knjige/članki

• Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
  od: van Steen, Sigrid C., et al.
  Izdano: (2018)
• The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial
  od: Blomster, Juuso I, et al.
  Izdano: (2016)
• Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial
  od: Batty, G. David, et al.
  Izdano: (2011)
• Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene
  od: Tremblay, Johanne, et al.
  Izdano: (2017)
• Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk
  od: Wang, Yujia, et al.
  Izdano: (2016)